We have developed ultrasound (US)-guided diffuse optical tomography (DOT) technique to assist US diagnosis of breast cancer and to predict neoadjuvant chemotherapy response of breast cancer patients. The technique was implemented using a hand-held hybrid probe consisting co-registered US transducer and optical source and detector fibers which couple the light illumination from laser diodes and photon detection to PMT detectors. With the US guidance, diffused light measurements were made at the breast lesion site and the normal contralateral reference site which was used to estimate the background tissue optical properties for imaging reconstruction. However, background optical properties were affected by the chest wall underneath the breast tissue. In this study, we have analyzed data from 297 female patients and results have shown statistical significant correlation between fitted optical properties (µa and µs') and the chest wall depth detected by a boundary detection algorithm applied to co-registered US images (r > 0.27, p < 1.0 × 10 -4 ). After subtracting the background total hemoglobin (tHb) computed with µa at each wavelength, the difference between malignant and benign lesion groups has improved. The Area-under-the-ROC curve (AUC) has improved from 88.5% to 91.5% (sensitivity improved from 85.0% to 87.5% and specificity from 90.2% to 92.6%). Statistical test has revealed significant difference of the AUC improvements after subtracting background tHb values.
Introduction
Diffused optical spectroscopy and tomography (DOS and DOT) techniques have been investigated extensively in the past two decades for their utility in breast cancer diagnosis and treatment monitoring. (1) (2) (3) (4) (5) (6) (7) (8) One method of using DOT in breast tissue characterization is to excite the breast tissue with modulated light in frequency domain and quantify the change of reflected diffuse light at certain distance from the source. Since this change can be described with amplitude attenuation and phase shifting from the source signal, and the logarithmic amplitude attenuation and phase are linearly related with source-detector separation, with slopes equal to the imaginary and real part of the propagation constant (ki, kr) of light in tissue, one can fit this constant with measurements at multiple source-detector separations. Then tissue absorption and reduced scattering coefficients (µa and µs') can be calculated from fitted ki and kr. With µa measured at several wavelengths in the near infrared range, where hemoglobin can be assumed to be the main absorber in tissue, one can compute the hemoglobin concentration by which to monitor breast physiological changes in vivo. This method has been tested to be effective in breast tissue characterization, however, using a reflective measurement setup, the chest wall muscle tends to affect the detected light with longer source-detector pairs, and thus results in inaccurate tissue properties measured. with liquid breast tissue phantom and solid chest wall phantom. (10) By immersing the probe in the breast tissue mimicking solution made with intralipid and ink, and adjusting the distance from probe to the solid phantom at bottom, results show data at longer source-to-detector positions were dragged down, resulting in in-accurate fitting of solution properties. Since then, we have developed a couple of methods to minimize the chest wall effect, including a twolayer modeling (11) and a two-layer reconstruction method, (12) and a two-step fitting and reconstruction with a dual probe measurements (a small probe for the first layer and a larger probe for both layers). (13) Despite the promising results, the clinical application of these methods is limited due to their intense computation and a slower convergence rate. (11, 13) By doing a thorough literature review on the DOT systems developed by other groups, we found they either used the plates, ring shaped or hand-held probe for housing the sources and detectors. And in terms of the subjects' gestures, they either sit, stand, lie prone or supine during the experiment. According to our understanding, the system that uses hand-held probe with participants lie supine in bed during experiments are most likely to be affected by the chest wall effect on their acquired data. The recent paper by Nobuko et al. reported about the effect of chest wall on measured total hemoglobin (tHb) using their TR-DOS system. (14) They developed a hand-held probe with 3 cm sourceto-detector distance. Result shows a clear relationship between the measured tHb and chest wall depth, with larger tHb values measured at shorter source-detector pairs. They also proposed to use a straightforward subtraction method to remove the chest wall effect from their measurements.
In this study, the correlation between the fitted background tissue optical properties and the chest wall depth from 297 patients measured with our FD-DOT system was evaluated. The background optical properties were measured from the contralateral reference breast at the mirror position of the lesion. And the chest wall depth was measured with a customized chest wall detection algorithm from co-registered US images. We validated the depth by an expert with US images. Using lesion tHb values reported in Ref. 16 , we have subtracted the background hemoglobin level from each patient's tHb to improve diagnosis between malignant and benign lesions.
Materials and Methods

Study Subjects
We evaluated 297 female patients' data in this study. All patients signed the informed consent and the protocol was approved by local Institution Review Boards. Characteristics of study subjects can be found from Ref. 16 , and for this study, we have totally 303 measurements from 297 subjects analyzed for lesion diagnosis. 12 individuals with no US identifiable lesions at the time of DOT study were taken as a control. In evaluating lesion diagnosis, the benign lesions are further divided into: proliferative lesions (Prolif., n=33), fibroadenoma (FA, n=75), fat necrosis and inflammatory changes (FN, n=29), fibrocystic changes (FC, n=44), cystic changes (Cyst, n=38), lymph node (LN, n=6), breast tissue and other benign categories (n=7), while malignant lesions are further divided into: early stage, Tis-T1 (n=40) and later stage, T2-T4 (n=19).
US-guided DOT imaging and data processing
Fig. 1 Illustration of measurement procedures (left) and probe geometry (right).
The specifications of our US-guided FD-DOT system were described elsewhere. (15, 16) Briefly, four laser diodes sequentially delivered four optical wavelengths light of 740 nm, 780 nm, 808 nm and 830 nm to 9 source locations and the reflected light was detected by 10 detecting fibers (Fig. 1) . Optical fibers were used for delivering light signal from the laser sources to breast tissue, and from tissue to photomultiplier tube (PMT) detectors. The tip of source and detector fibers were distributed uniformly on the surface of combined probe. A commercial ultrasound probe at the center was used to acquire co-registered US images (Fig. 1) . In doing the experiment, 4-6 DOT datasets were first acquired just on top of the lesion and then probe was moved to the contralateral breast side and collected 4-5 reference datasets. US images were used carefully used for making reference detecting spot at the mirror location of lesion, and also make sure chest wall depths are similar for both lesion and reference locations.
Fig. 2 An example of DOT fitting of the reference properties
Background tissue µa and µs' were fitted from the reflectance measurements made at the contralateral normal breast using semi-infinite analytical solution. (17) For each wavelength, the absorption µa and reduced scattering coefficients µs' are fitted as:
(1)
Where is the modulation frequency and is the speed of light. and are the fitted slopes of amplitude (logarithmic scale) and phase versus source and detector distance (Fig. 2) . The average µa and µs' obtained from the reference side breast were used to characterize each patient's background tissue optical properties and generate a weight matrix for lesion properties reconstruction. Reconstruction of an absorption (µa) map of a lesion at each wavelength is based on the Born approximation and conjugate gradient search for optimization. (18) The tHb map of a lesion was directly computed by summation of HbO2 and Hb from reconstructed µa maps at four wavelengths from equation (3): (19) 
The maximum values in computed tHb maps with lesion side reconstructed µas was used to characterize the lesion. Bulk tissue or background tissue tHb concentration was calculated from fitted µa values. To minimize the chest wall effect, the lesion tHb was subtracted by background hemoglobin level, which represents a relative tHb concentration (ΔtHb).
Chest wall depth detection
The chest wall depth was detected by using an automatic chest wall detecting algorithm developed by our group. Briefly, we first applied the Canny edge detection method to convert an US image to a binary image, then the Hough Transform was used to detect all line structures in the image. Later, we applied empirical restrictions on the detected ,.,, t r, x :.t.
.
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lines which include the line length, rough location and line slop range, and the final survived structures are decided to be the chest wall.
Statistical Analysis
We computed the Pearson correlation coefficients to examine the correlations of the fitted µa and µs' with the chest wall depth. Two-sample t-test was performed to compare the mean difference of tHb between the malignant group and each benign sub-group (p-values). In order to evaluate the diagnostic performance of tHb levels in classification of malignant and benign lesions, the tHb levels were used as the predictor variable and the respond variable is a binary corresponding to the status of tumor diagnosis based on biopsy. For analysis of early cases, the respond variable is unity for early stage malignant tumors (Tis-T1) and zero for benign lesions. The false positive rate (1-specificity) and true positive rate (sensitivity) were computed in Matlab to generate the receiver operating characteristic curve (ROC).
In each ROC plot, the area under the ROC (AUC), the corresponding 95% confidence interval (CI) and the statistical difference of AUCs with and without subtracting background were calculated using R package pROC. (20) For all tests statistical significance was considered at p < 0.05.
Results
Operator manually detected chest wall depths were compared with algorithm automatic detection. Using an error measure defined by
, the percentage of cases with error <15% was 67%. For cases with error > 15%, the operator re-evaluated the chest wall depths and reassigned or confirmed the values. Of all cases, an average algorithm detection error was 14%, which corresponds to 2 to 4 mm for the average chest wall depth of 2 to 3 cm.
We then analyzed the correlation between fitted background µa and µs' and the chest wall depth of the reference side which does not have known lesions at the time of the study based on the evaluations of the attending radiologists from available mammograms, US, and or magnetic resonance imaging (MRI). The fitted µa and µs' at four optical wavelengths are correlated with the chest wall depth as shown in Fig. 3 with all p-values less than 0.0001. At each wavelength, the fitted µa has a much higher correlation coefficient than that of fitted µs'. We further calculated the hemoglobin concentrations from fitted bulk tissue µas at four wavelengths. The correlation coefficients (r) and pvalues between chest wall depth and computed background hemoglobin values were, tHb: r = 0.6775, p < 0.0001; HbO2: r = 0.6134, p < 0.0001; and Hb: r = 0.6017, p < 0.0001, which are statistically significant. subtraction of the corresponding background between malignant group (both Tis-T1 and T2-T4) and benign subgroups of Prolif., FA, FN, FC, Cyst, LN and all-benign group. The error bars in Fig. 4 indicate the standard deviations of the difference between malignant group and each benign sub-group. They were computed using the Stds and sample sizes (n) of two groups under comparison as Std = √ 2 . An increased difference was found between the malignant group and 6 of the 7 benign sub-groups in a range of 2-7 µM, except for the tissue & other benign group, which has a small sample size. The largest difference after subtraction was found from fibroadenoma (FA) due to the relative young patients with dense breast tissue and a shallower chest wall depth in this group. The ROC curves (sensitivity vs. 1-specificity) using a threshold of tHb level for predicting early stage malignant lesions (Tis-T1) from the benign cases are analyzed and shown in Fig. 5 . We compared both ROCs and AUCs in R package pROC (20) using tHb levels before and after subtracting the background. We observed a significantly higher AUC for Tis-T1 diagnosis with an increased AUC of 3.0% (p = 0.0016). The above results have demonstrated that background subtraction method has consistently improved diagnostic performance for early breast lesions. From the ROC curves, 64 µM was chosen as the optimal threshold for diagnosis using relative lesion tHb after subtracting the background values, and 80 µM was used as the optimal threshold for diagnosis using the reconstructed tHb without subtracting the background values. We then computed the sensitivity, specificity, positive predictive value (PPVs) and negative predictive value (NPVs) in diagnosing early malignant tumor from the benign lesions using tHb data with and without subtracting the background data. Results show an improvement of 2.5% in sensitivity, 2.4% in specificity, 7.4% in PPV and around 0.4% in NPV after subtracting the background values. 
Discussion and Summary
The fitted µa and µs' measured in the reflection geometry using larger source and detector separations are not true representation of tissue background optical properties due to the influence of chest wall underneath the breast tissue. This suggests that diagnosis between malignant and benign lesions is best performed by using relative hemoglobin concentrations after subtracting corresponding background values computed from fitted µas at multiple optical wavelengths. Another advantage of using relative hemoglobin values for diagnosis is that this method eliminates the effect due to hemoglobin level fluctuations in certain type of patients who may be under anemia or some drug effect. For those patients, the background blood hemoglobin concentration differs significantly from the normal values.
We have developed an automated chest wall detection algorithm to mark the chest wall depth from coregistered ultrasound images. It is also a valuable tool to guide operators to position the hand-held probe at the matched chest wall positions of reference and lesion breasts to achieve best performance in computing perturbations and reconstructing accurate lesion optical properties.
In summary, we have analyzed data from 297 female patients and results have shown statistical significant correlation between fitted optical properties (µa and µs') and the chest wall depth detected by a boundary detection algorithm applied to co-registered US images (r > 0.27, p < 1.0 × 10 -4 ). After subtracting the background µa at each wavelength, the difference of computed total hemoglobin (tHb) between malignant and benign lesion groups has improved. The Area-under-the-ROC curve (AUC) has improved from 88.5% to 91.5% (sensitivity improved from 85.0% to 87.5% and specificity from 90.2% to 92.6%).
